Sinopharm Efficacy Rate: China’s COVID-19 Vaccine Gets WHO Approval for Adult Emergency Use

Sinopharm Efficacy Rate: China’s COVID-19 Vaccine Gets WHO Approval for Adult Emergency Use

HNGN

Published

The World Health Organization (WHO) stated on Friday it has approved for emergency use a COVID-19 vaccine developed by Chinese state-owned pharmaceutical group Sinopharm. Sinopharm's vaccine is the sixth to receive the WHO’s approval for efficacy, safety, and quality.

Full Article